Story

Egide H1 Revenue Slips 2.4% as U.S. Delays Offset Thermal Imaging Strength

ENTHMSVIIDZHZH-TWJAKOHI
Jul 27, 20261 min read
Egide H1 Revenue Slips 2.4% as U.S. Delays Offset Thermal Imaging Strength

Summary

The French hermetic package maker reported first-half revenue of €15.20 million, with a 33% plunge in its U.S. business masking a 23% surge in its thermal imaging segment.

Text size
Background

Egide SA (ALGID), a French manufacturer of specialized hermetic packages, reported a 2.4% decline in first-half 2026 revenue on a reported basis, citing significant operational challenges in the United States. The company's revenue for the period reached €15.20 million, though it noted a modest increase of 0.7% at constant exchange rates.

U.S. Operations Weigh on Results

The primary driver of the revenue decline was Egide's U.S. division, which saw its revenue plummet by 33%. According to the company's report, this sharp drop was caused by two main factors:

  • Temporary delays in the ramp-up of key customer programs.
  • A halt in production at its Santier facility.

These setbacks in the American market significantly impacted the group's consolidated top-line performance for the first six months of the year.

Mixed Performance Across Segments

Sample IUX Markets – In-articleAd

While the U.S. business struggled, Egide's thermal imaging segment delivered strong growth, with revenue climbing 23%. This division has become a critical part of the company's business, now accounting for 55% of total group revenue and helping to partially offset weakness elsewhere.

Conversely, the power segment experienced a steep 64% fall in revenue. Egide attributed this decline to a deliberate strategic shift as the company moves its focus toward other strategic applications.

Cautious Outlook for H2

Looking ahead, Egide management stated it expects business in the second half of 2026 to be weaker than in the first half. The company's ability to convert its existing backlog into revenue will depend heavily on the successful ramp-up of its Cambridge facility.

Despite the forecast for a softer second half, Egide said it still anticipates achieving positive year-over-year growth for the full-year 2026 performance.

Read next

More on Stocks
Back to latest news

LATEST